Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05224> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05224 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05224 label "REP8839 [drugbank:DB05224]" assertion.
- drugbank:DB05224 seeAlso DB05224 assertion.
- drugbank:DB05224 identifier "drugbank:DB05224" assertion.
- drugbank:DB05224 description "REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003)." assertion.
- drugbank:DB05224 title "REP8839" assertion.
- drugbank:DB05224 bio2rdf_vocabulary:identifier "DB05224" assertion.
- drugbank:DB05224 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05224 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05224" assertion.
- drugbank:DB05224 bio2rdf_vocabulary:x-identifiers.org DB05224 assertion.
- drugbank:DB05224 drugbank_vocabulary:drugbank-id "DB05224" assertion.
- drugbank:DB05224 drugbank_vocabulary:x-cas cas: assertion.